Don’t forget that all Gastro Bites webinars are available free for members to watch on-demand! Last month, Drs. Michael Dougan, Joanna Peloquin Melia and Shrinivas Bishu hosted a Gastro Bites discussion on GI toxicities from cancer immunotherapy.
Immunotherapy has transformed the treatment landscape for cancer, leading to durable remissions in patients with previously refractory disease. The promise of these treatments is limited by inflammatory toxicities that can target any system in the body. Gastrointestinal toxicities, in particular colitis and enterocolitis, are the most common severe toxicities induced by cancer immunotherapy and are a major reason for treatment discontinuation.
During the chat, the speakers discuss real-life cases involving these toxicities and how they would each approach treatment.
Learning objectives
Meet the speakers
Michael Dougan, MD, PhD
Assistant Professor
Massachusetts General Hospital and Harvard Medical School
Joanna Peloquin Melia, MD
Assistant Professor
Division of Gastroenterology and Hepatology
Johns Hopkins
Shrinivas Bishu, MD
Assistant Professor
University of Michigan
